Prelude Therapeutics Statistics
Total Valuation
PRLD has a market cap or net worth of $450.59 million. The enterprise value is $386.76 million.
Important Dates
The last earnings date was Tuesday, May 12, 2026, before market open.
| Earnings Date | May 12, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
PRLD has 100.58 million shares outstanding. The number of shares has increased by 3.59% in one year.
| Current Share Class | 66.32M |
| Shares Outstanding | 100.58M |
| Shares Change (YoY) | +3.59% |
| Shares Change (QoQ) | +3.52% |
| Owned by Insiders (%) | 4.48% |
| Owned by Institutions (%) | 10.19% |
| Float | 28.99M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 26.95 |
| Forward PS | n/a |
| PB Ratio | 4.69 |
| P/TBV Ratio | 7.49 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Financial Ratio HistoryEnterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | 23.13 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 2.03, with a Debt / Equity ratio of 0.29.
| Current Ratio | 2.03 |
| Quick Ratio | 1.95 |
| Debt / Equity | 0.29 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | n/a |
Financial Efficiency
Return on equity (ROE) is -95.25% and return on invested capital (ROIC) is -52.03%.
| Return on Equity (ROE) | -95.25% |
| Return on Assets (ROA) | -39.69% |
| Return on Invested Capital (ROIC) | -52.03% |
| Return on Capital Employed (ROCE) | -106.31% |
| Weighted Average Cost of Capital (WACC) | 9.91% |
| Revenue Per Employee | $211,646 |
| Profits Per Employee | -$984,785 |
| Employee Count | 79 |
| Asset Turnover | 0.13 |
| Inventory Turnover | n/a |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +396.18% in the last 52 weeks. The beta is 1.10, so PRLD's price volatility has been higher than the market average.
| Beta (5Y) | 1.10 |
| 52-Week Price Change | +396.18% |
| 50-Day Moving Average | 4.05 |
| 200-Day Moving Average | 2.29 |
| Relative Strength Index (RSI) | 50.15 |
| Average Volume (20 Days) | 556,202 |
Short Selling Information
The latest short interest is 1.55 million, so 1.55% of the outstanding shares have been sold short.
| Short Interest | 1.55M |
| Short Previous Month | 1.81M |
| Short % of Shares Out | 1.55% |
| Short % of Float | 5.36% |
| Short Ratio (days to cover) | 3.44 |
Income Statement
In the last 12 months, PRLD had revenue of $16.72 million and -$77.80 million in losses. Loss per share was -$1.00.
| Revenue | 16.72M |
| Gross Profit | 16.72M |
| Operating Income | -82.84M |
| Pretax Income | -77.80M |
| Net Income | -77.80M |
| EBITDA | -81.17M |
| EBIT | -82.84M |
| Loss Per Share | -$1.00 |
Full Income StatementBalance Sheet
The company has $81.55 million in cash and $17.72 million in debt, with a net cash position of $63.83 million or $0.63 per share.
| Cash & Cash Equivalents | 81.55M |
| Total Debt | 17.72M |
| Net Cash | 63.83M |
| Net Cash Per Share | $0.63 |
| Equity (Book Value) | 60.18M |
| Book Value Per Share | 0.96 |
| Working Capital | 42.87M |
Full Balance SheetCash Flow
In the last 12 months, operating cash flow was -$43.76 million and capital expenditures -$20,000, giving a free cash flow of -$43.78 million.
| Operating Cash Flow | -43.76M |
| Capital Expenditures | -20,000 |
| Depreciation & Amortization | 1.67M |
| Net Borrowing | -53,000 |
| Free Cash Flow | -43.78M |
| FCF Per Share | -$0.44 |
Full Cash Flow StatementMargins
| Gross Margin | 100.00% |
| Operating Margin | -495.44% |
| Pretax Margin | -465.30% |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
PRLD does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -3.59% |
| Shareholder Yield | -3.59% |
| Earnings Yield | -17.27% |
| FCF Yield | -9.72% |
Analyst Forecast
The average price target for PRLD is $6.50, which is 45.09% higher than the current price. The consensus rating is "Strong Buy".
| Price Target | $6.50 |
| Price Target Difference | 45.09% |
| Analyst Consensus | Strong Buy |
| Analyst Count | 4 |
| Revenue Growth Forecast (5Y) | n/a |
| EPS Growth Forecast (5Y) | n/a |
Stock ForecastsFair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | 2 |
